Bacterial keratitis is a vision-threatening infection mainly caused by Gram-positive bacteria (GPB). Antimicrobial therapy is commonly empirical using broad-spectrum agents with efficacy increasingly compromised by the emergence of antimicrobial resistance. We used a combination of phenotypic tests and genome sequencing to identify the predominant lineages of GPB causing keratitis and to characterize their antimicrobial resistance patterns. A total of 161 isolates, including ( = 86), coagulase-negative staphylococci (CoNS; = 34), spp. ( = 34), and ( = 7), were included. The population of isolates consisted mainly of clonal complex 5 (CC5) (30.2%). Similarly, the population of was homogenous with most of them belonging to CC2 (78.3%). Conversely, the genetic population of was highly diverse. Resistance to first-line antibiotics was common among staphylococci, especially among CC5 . Methicillin-resistant was commonly resistant to fluoroquinolones and azithromycin (78.6%) and tobramycin (57%). One-third of the CoNS were resistant to fluoroquinolones and 53% to azithromycin. Macrolide resistance was commonly caused by genes in , and in CoNS, and ) in streptococci. Aminoglycoside resistance in staphylococci was mainly associated with genes commonly found in mobile genetic elements and that encode for nucleotidyltransferases like and . Fluroquinolone-resistant staphylococci carried from 1 to 4 quinolone resistance-determining region mutations, mainly in the and genes. We found that GPB causing keratitis are associated with strains commonly resistant to first-line topical therapies, especially staphylococcal isolates that are frequently multidrug-resistant and associated with major hospital-adapted epidemic lineages.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10916405 | PMC |
http://dx.doi.org/10.1128/aac.01247-23 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!